MTOR and cancer: Aging‐related disorders such as cancers, diabetes, cardiovascular, and neurodegenerative diseases, as well as normal aging, have been linked to dysregulated signaling of the mechanistic target of rapamycin (mTOR) pathway (Dazert & Hall, 2011).